RetinoStat
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RetinoStat, covering 2017-04-05 to 2026-01-14. Get the full timeline:
Most recent: Clinical Trial Update: A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration [Phase 1]